Inventor

LEBLANC CATHERINE

CH35 patents

⚠️ This page may combine multiple inventors who share the name “LEBLANC CATHERINE”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

LEBLANC CATHERINE

NOVARTIS AG

Pyrrolopyridine derivatives and their use as Crth2 antagonists

Pyrimidine derivatives as alk-5 inhibitors

Pharmaceutical combinations

Organic compounds

Organic compounds

5-phenylthiazole derivatives and use as Pi3 kinase inhibitors

Pyrrolopyridine derivatives and their use as CRTH2 antagonists

Formylated N-heterocyclic derivatives as FGFR4 inhibitors

Pyrrolopyridine derivatives and their use as CRTH2 antagonists

Substituted pyrrolo[2,3-B]pyrazines for the treatment of disorders and diseases

Substituted pyrrolo[2,3-B]pyrazine compounds and their use

5-phenyl-4-methyl-thiazol-2-yl-amine derivatives as inhibitors of phosphatidylin ositol 3 kinase enzymes (PI13) for treatment of inflammatory diseases

Use of ring-fused bicyclic pyridyl derivatives as FGFR4 inhibitors

Pyrazolyl derivatives useful as anti-cancer agents

Compounds and compositions for inhibiting the activity of HIF2-alpha and their methods of use

IP receptor agonist heterocyclic compounds

5-Phenylthiazole derivatives and their use as p13 kinase inhibitors

BUSCHMANN NICOLE

Ring-fused bicyclic pyridyl derivatives as FGFR4 inhibitors

Ring-fused bicyclic pyridyl derivatives as FGFR4 inhibitors

Ring-fused bicyclic pyridyl derivatives as FGFR4 inhibitors

Particles of N-(5-cyano-4-((2-methoxyethyl)amino)pyridin-2-yl)-7-formyl-6-((4-methyl-2-oxopiperazin-1-yl)methyl)-3,4-dihydro-1,8-naphthyridine-1(2H)-carboxamide

Formylated N-heterocyclic derivatives as FGFR4 inhibitors

LEBLANC CATHERINE

Pyrrolopyrimidines and pyrrolopyridines

Salts of 7-(2,3-di-p-tolyl-7,8-dihydropyrido[2,3-b]pyrazin-5(6H)-yl)heptanoic acid as IP receptor agonists

Imidazo-pyridine derivatives as activin-like receptor kinase (ALK4 or ALK5) inhibitors

Bacterial iodoperoxidases from Zobellia galactanivorans, methods of preparation and uses thereof

CHARLTON STEVEN JOHN

Substituted pyrido[2,3-B]pyrazines as IP receptor agonists

Pyrido[2,3-b]pyrazine compounds useful as IP receptor agonist

Substituted pyrido[2,3-B]pyrazines as IP receptor agonists

BALA KAMLESH JAGDIS

Organic compounds

Pyrrolopyridine derivatives and their use as CRTH2 antagonists

HUNT PETER

Organic compounds

BRUCE IAN

5-phenylthiazole derivatives and use as PI3 kinase inhibitors

SANDHAM DAVID ANDREW

Pyrrolopyridine compounds and their use in treating disease

AXFORD JAKE

Organic compounds for the treatment of inflammatory or allergic conditions